141 related articles for article (PubMed ID: 37846634)
1. [Exosomes in the diagnosis of prostate cancer: Advances in studies].
Zhao XD; Chen YQ; Liu Z; Xu S
Zhonghua Nan Ke Xue; 2022 Dec; 28(12):1123-1128. PubMed ID: 37846634
[TBL] [Abstract][Full Text] [Related]
2. Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis.
Barceló M; Castells M; Bassas L; Vigués F; Larriba S
Sci Rep; 2019 Sep; 9(1):13772. PubMed ID: 31551516
[TBL] [Abstract][Full Text] [Related]
3. Increased PSA expression on prostate cancer exosomes in in vitro condition and in cancer patients.
Logozzi M; Angelini DF; Iessi E; Mizzoni D; Di Raimo R; Federici C; Lugini L; Borsellino G; Gentilucci A; Pierella F; Marzio V; Sciarra A; Battistini L; Fais S
Cancer Lett; 2017 Sep; 403():318-329. PubMed ID: 28694142
[TBL] [Abstract][Full Text] [Related]
4. Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer.
Wang J; Ni J; Beretov J; Thompson J; Graham P; Li Y
Crit Rev Oncol Hematol; 2020 Jan; 145():102860. PubMed ID: 31874447
[TBL] [Abstract][Full Text] [Related]
5. Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer.
Wang YH; Ji J; Wang BC; Chen H; Yang ZH; Wang K; Luo CL; Zhang WW; Wang FB; Zhang XL
Cell Physiol Biochem; 2018; 46(2):532-545. PubMed ID: 29614511
[TBL] [Abstract][Full Text] [Related]
6. Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.
Valentino A; Reclusa P; Sirera R; Giallombardo M; Camps C; Pauwels P; Crispi S; Rolfo C
Clin Transl Oncol; 2017 Jun; 19(6):651-657. PubMed ID: 28054319
[TBL] [Abstract][Full Text] [Related]
7. Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer.
Khan S; Jutzy JM; Valenzuela MM; Turay D; Aspe JR; Ashok A; Mirshahidi S; Mercola D; Lilly MB; Wall NR
PLoS One; 2012; 7(10):e46737. PubMed ID: 23091600
[TBL] [Abstract][Full Text] [Related]
8. Impact of Extracellular Vesicle Isolation Methods on Downstream Mirna Analysis in Semen: A Comparative Study.
Mercadal M; Herrero C; López-Rodrigo O; Castells M; de la Fuente A; Vigués F; Bassas L; Larriba S
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32824915
[TBL] [Abstract][Full Text] [Related]
9. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.
Sánchez CA; Andahur EI; Valenzuela R; Castellón EA; Fullá JA; Ramos CG; Triviño JC
Oncotarget; 2016 Jan; 7(4):3993-4008. PubMed ID: 26675257
[TBL] [Abstract][Full Text] [Related]
10. The discriminative ability of Prostate Health Index to detect prostate cancer is enhanced in combination with miR-222-3p.
Tölle A; Jung K; Friedersdorff F; Maxeiner A; Lein M; Fendler A; Stephan C
Cancer Biomark; 2021; 30(4):381-393. PubMed ID: 33361585
[TBL] [Abstract][Full Text] [Related]
11. MiR-375 and miR-21 as Potential Biomarkers of Prostate Cancer: Comparison of Matching Samples of Plasma and Exosomes.
Joković SM; Dobrijević Z; Kotarac N; Filipović L; Popović M; Korać A; Vuković I; Savić-Pavićević D; Brajušković G
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553586
[TBL] [Abstract][Full Text] [Related]
12. Application of extracellular vesicles in the diagnosis and treatment of prostate cancer: Implications for clinical practice.
Oey O; Ghaffari M; Li JJ; Hosseini-Beheshti E
Crit Rev Oncol Hematol; 2021 Nov; 167():103495. PubMed ID: 34655743
[TBL] [Abstract][Full Text] [Related]
13. Exosomes as A Next-Generation Diagnostic and Therapeutic Tool in Prostate Cancer.
Gaglani S; Gonzalez-Kozlova E; Lundon DJ; Tewari AK; Dogra N; Kyprianou N
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576294
[TBL] [Abstract][Full Text] [Related]
14. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.
Salido-Guadarrama AI; Morales-Montor JG; Rangel-Escareño C; Langley E; Peralta-Zaragoza O; Cruz Colin JL; Rodriguez-Dorantes M
Mol Med Rep; 2016 Jun; 13(6):4549-60. PubMed ID: 27081843
[TBL] [Abstract][Full Text] [Related]
15. Exosomes-based biomarker discovery for diagnosis and prognosis of prostate cancer.
Panigrahi GK; Deep G
Front Biosci (Landmark Ed); 2017 Jun; 22(10):1682-1696. PubMed ID: 28410139
[TBL] [Abstract][Full Text] [Related]
16. Proteomics in diagnosis of prostate cancer.
Davalieva K; Polenakovic M
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):5-36. PubMed ID: 26076772
[TBL] [Abstract][Full Text] [Related]
17. Plasma extracellular vesicles as phenotypic biomarkers in prostate cancer patients.
Joncas FH; Lucien F; Rouleau M; Morin F; Leong HS; Pouliot F; Fradet Y; Gilbert C; Toren P
Prostate; 2019 Nov; 79(15):1767-1776. PubMed ID: 31475741
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes.
Salciccia S; Capriotti AL; Laganà A; Fais S; Logozzi M; De Berardinis E; Busetto GM; Di Pierro GB; Ricciuti GP; Del Giudice F; Sciarra A; Carroll PR; Cooperberg MR; Sciarra B; Maggi M
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922033
[TBL] [Abstract][Full Text] [Related]
19. Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers.
Filella X; Foj L
Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27792187
[TBL] [Abstract][Full Text] [Related]
20. The utility of PSA velocity in prediction of prostate cancer and high grade cancer after an initially negative prostate biopsy.
Elshafei A; Li YH; Hatem A; Moussa AS; Ethan V; Krishnan N; Li J; Jones JS
Prostate; 2013 Dec; 73(16):1796-802. PubMed ID: 24038200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
